Vistagen Therapeutics, Inc.
VTGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411685
No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Vistagen Therapeutics, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 55 | 1 | 56 | +2 |
| Shares | 13.8M | 1.82M | 14.7M | +2.80M (+23.5%) |
| Value | $8.84M | $1.21M | $8.12M | +$496.5K (+6.5%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Vistagen Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 1,574,200 | $900.4K | 0.00% |
| Acadian Asset Management LLC | 589,663 | $336.0K | 0.00% |
| Vanguard Fiduciary Trust Co | 217,700 | $124.5K | 0.00% |
| Verdad Advisers, LP | 184,938 | $105.7K | 0.12% |
| XTX Topco Ltd | 152,849 | $87.4K | 0.00% |
| Shay Capital LLC | 144,452 | $82.6K | 0.01% |
| Simplex Trading, LLC | 89,649 | $51.3K | 0.00% |
| Prudential Financial Inc | 53,100 | $30.3K | 0.00% |
| Gsa Capital Partners LLP | 49,842 | $28.0K | 0.00% |
| Two Sigma Securities, LLC | 16,495 | $9.43K | 0.00% |
| Raymond James Financial Inc | 14,884 | $8.51K | 0.00% |
| Vanguard Global Advisers, LLC | 10,809 | $6.18K | 0.00% |
| Royal Bank of Canada | 2,127 | $1.00K | 0.00% |
| Annis Gardner Whiting Capital Advisors, LLC | 600 | $343 | 0.00% |
| Northwestern Mutual Wealth Management Co | 16 | $9 | 0.00% |
| Citigroup Inc | 1 | $1 | 0.00% |
Sold out (14)
Institutions that held Vistagen Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Dimensional Fund Advisors LP | 151,874 | $100.6K |
| Two Sigma Advisers, LP | 137,732 | $91.2K |
| Omers Administration Corp | 103,400 | $68.4K |
| Seven Fleet Capital Management LP | 62,701 | $41.5K |
| Qube Research & Technologies Ltd | 60,139 | $39.8K |
| Occudo Quantitative Strategies LP | 59,038 | $39.1K |
| American Century Companies Inc | 48,770 | $32.3K |
| Virtu Financial LLC | 37,739 | $25.0K |
| Engineers Gate Manager LP | 30,490 | $20.2K |
| Charles Schwab Investment Management Inc | 23,302 | $15.4K |
| Lighthouse Investment Partners, LLC | 20,580 | $13.6K |
| Marshall Wace, LLP | 19,973 | $13.2K |
| DRW Securities, LLC | 10,000 | $6.62K |
| Bank of America Corp | 3,145 | $2.08K |
Not filed for Q1 2026 yet (1)
Institutions that held Vistagen Therapeutics, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 1,824,738 | $1.21M |